VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Several vascular disorders, such as aberrant angiogenesis, atherosclerosis and pulmonary hypertension, have been linked to dysfunctional BMP signaling. Vascular hyperpermeability via distortion of endothelial cell adherens junctions is a common feature of these diseases, but the role of BMPs in this process has not been investigated. BMP signaling is initiated by binding of ligand to, and activation of, BMP type I (BMPRI) and type II (BMPRII) receptors. Internalization of VE-cadherin as well as c-Src kinase-dependent phosphorylation have been implicated in the loosening of cell–cell contacts, thereby modulating vascular permeability. Here we demonstrate that BMP6 induces hyperpermeabilization of human endothelial cells by inducing internalization and c-Src-dependent phosphorylation of VE-cadherin. Furthermore, we show BMP-dependent physical interaction of VE-cadherin with the BMP receptor ALK2 (BMPRI) and BMPRII, resulting in stabilization of the BMP receptor complex and, thereby, the support of BMP6-Smad signaling. Our results provide first insights into the molecular mechanism of BMP-induced vascular permeability, a hallmark of various vascular diseases, and provide the basis for further investigations of BMPs as regulators of vascular integrity, both under physiological and pathophysiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513 · cited 1×
“Thus, the integrity of the endothelial barrier is essential for physiological tissue homeostasis, and hyperpermeability is involved in the progression of several pathological conditions, including inflammation, atherosclerosis and cancer (Davignon and Ganz, 2004; Weis and Cheresh, 2005).”
BackgroundDiscovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922 · cited 1×
“A common hallmark of these diseases is vascular hyperpermeability, causing plasma proteins or cells to enter the surrounding tissue, leading to the formation of edema, plaques or metastases (Kumar et al., 2009; Reymond et al., 2013).”
BackgroundLuissint, A.-C., Artus, C., Glacial, F., Ganeshamoorthy, K., & Couraud, P.-O. (2012) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-9-23 · Cited by 654 · cited 1×
“TJs mediate intercellular adhesion by the formation of complexes between several members of the claudin, occludin and junctional adhesion molecule (JAM) protein families and have been implicated in the regulation of the blood–brain barrier (Luissint et al., 2012).”
BackgroundVinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling
Huveneers, S., Oldenburg, J., Spanjaard, E., van der Krogt, G., Grigoriev, I., Akhmanova, A., Rehmann, H., & de Rooij, J. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201108120 · Cited by 481
Wessel, F., Winderlich, M., Holm, M., Frye, M., Rivera-Galdos, R., Vockel, M., Linnepe, R., Ipe, U., Stadtmann, A., Zarbock, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2824 · Cited by 354
Research works printed but not linked: 65
- Adam, 2010, Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers, J. Biol. Chem., 285, 7045, 10.1074/jbc.M109.079277 · DOI · Paper page
- Allalou, 2009, BlobFinder, a tool for fluorescence microscopy image cytometry, Comput. Methods Programs Biomed., 94, 58, 10.1016/j.cmpb.2008.08.006 · DOI
- Andriopoulou, 1999, Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions, Arterioscler. Thromb. Vasc. Biol., 19, 2286, 10.1161/01.ATV.19.10.2286 · DOI · Paper page
- Angelini, 2006, TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia, Am. J. Physiol. Lung Cell. Mol. Physiol., 291, L1232, 10.1152/ajplung.00109.2006 · DOI · Paper page
- Bauer, 2005, Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis, Proc. Natl. Acad. Sci. USA, 102, 204, 10.1073/pnas.0406092102 · DOI · Paper page
- Behzadian, 2001, TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function, Invest. Ophthalmol. Vis. Sci., 42, 853
- Bhushan, 2013, miR-181a promotes osteoblastic differentiation through repression of TGF-beta signaling molecules, Int. J. Biochem. Cell Biol., 45, 696, 10.1016/j.biocel.2012.12.008 · DOI
- Bravi, 2014, VE-cadherin at a glance, Cell Tissue Res., 355, 515, 10.1007/s00441-014-1843-7 · DOI
- Cai, 2012, BMP signaling in vascular diseases, FEBS Lett., 586, 1993, 10.1016/j.febslet.2012.04.030 · DOI · Paper page
- Chen, 2003, Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling, Science, 301, 1394, 10.1126/science.1083195 · DOI · Paper page
- Corada, 2001, Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability, Blood, 97, 1679, 10.1182/blood.V97.6.1679 · DOI · Paper page
- Cuny, 2008, Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors, Bioorg. Med. Chem. Lett., 18, 4388, 10.1016/j.bmcl.2008.06.052 · DOI · Paper page
- Dejana, 2008, The role of adherens junctions and VE-cadherin in the control of vascular permeability, J. Cell Sci., 121, 2115, 10.1242/jcs.017897 · DOI · Paper page
- Derwall, 2012, Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 32, 613, 10.1161/ATVBAHA.111.242594 · DOI · Paper page
- Dvorak, 1996, The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation, J. Leukoc. Biol., 59, 100, 10.1002/jlb.59.1.100 · DOI · Paper page
- Dyer, 2014, The role of BMPs in endothelial cell function and dysfunction, Trends Endocrinol. Metab., 25, 472, 10.1016/j.tem.2014.05.003 · DOI · Paper page
- Ehrlich, 2012, Oligomeric interactions of TGF-beta and BMP receptors, FEBS Lett., 586, 1885, 10.1016/j.febslet.2012.01.040 · DOI · Paper page
- Eliceiri, 1999, Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability, Mol. Cell, 4, 915, 10.1016/S1097-2765(00)80221-X · DOI · Paper page
- Esser, 1998, Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells, J. Cell Sci., 111, 1853, 10.1242/jcs.111.13.1853 · DOI · Paper page
- Gabriel, 2009, Measuring plasma membrane protein endocytic rates by reversible biotinylation, J. Vis. Exp., e1669, 10.3791/1669 · doi:10.3791/1669
- Gavard, 2006, VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin, Nat. Cell Biol., 8, 1223, 10.1038/ncb1486 · DOI · Paper page
- Gavard, 2008, Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia, Dev. Cell, 14, 25, 10.1016/j.devcel.2007.10.019 · DOI · Paper page
- Gilboa, 2000, Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors, Mol. Biol. Cell, 11, 1023, 10.1091/mbc.11.3.1023 · DOI · Paper page
- Goddard, 2013, Cellular and molecular regulation of vascular permeability, Thromb. Haemost., 109, 407, 10.1160/TH12-09-0678 · DOI
- Goumans, 2002, Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors, EMBO J., 21, 1743, 10.1093/emboj/21.7.1743 · DOI · Paper page
- Ha, 2008, A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor, J. Biol. Chem., 283, 7261, 10.1074/jbc.M702881200 · DOI · Paper page
- Hamdy, 1997, Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue, Cancer Res., 57, 4427
- Hartung, 2006, Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling, Mol. Cell. Biol., 26, 7791, 10.1128/MCB.00022-06 · DOI · Paper page
- Helbing, 2011, BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium, Blood, 118, 5040, 10.1182/blood-2011-03-339762 · DOI
- Helbing, 2013, Inhibition of BMP activity protects epithelial barrier function in lung injury, J. Pathol., 231, 105, 10.1002/path.4215 · DOI
- Hiepen, 2014, BMP2-induced chemotaxis requires PI3K p55gamma/p110alpha-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5beta recruitment at the cytocortex, BMC Biol., 12, 43, 10.1186/1741-7007-12-43 · DOI
- Hussein, 2014, Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy, Exp. Eye Res., 125, 79, 10.1016/j.exer.2014.05.012 · DOI
- Iyer, 2004, VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function, Am. J. Physiol. Lung Cell. Mol. Physiol., 286, L1143, 10.1152/ajplung.00305.2003 · DOI
- Korchynskyi, 2002, Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter, J. Biol. Chem., 277, 4883, 10.1074/jbc.M111023200 · DOI · Paper page
- Kronstein, 2012, Caveolin-1 opens endothelial cell junctions by targeting catenins, Cardiovasc. Res., 93, 130, 10.1093/cvr/cvr256 · DOI · Paper page
- Kumar, 2009, Molecular mechanisms of endothelial hyperpermeability: implications in inflammation, Expert Rev. Mol. Med., 11, e19, 10.1017/S1462399409001112 · DOI · Paper page
- Lampugnani, 1995, The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin), J. Cell Biol., 129, 203, 10.1083/jcb.129.1.203 · DOI · Paper page
- Lampugnani, 2006, Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments, J. Cell Biol., 174, 593, 10.1083/jcb.200602080 · DOI · Paper page
- Lawler, 1997, The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues, J. Biol. Chem., 272, 14850, 10.1074/jbc.272.23.14850 · DOI · Paper page
- Lee, 2012, BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2, J. Orthop. Res., 30, 1985, 10.1002/jor.22160 · DOI
- Lin, 1998, beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor, J. Biol. Chem., 273, 31640, 10.1074/jbc.273.48.31640 · DOI · Paper page
- Luttrell, 1999, Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes, Science, 283, 655, 10.1126/science.283.5402.655 · DOI · Paper page
- Pepper, 1993, Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis, Exp. Cell Res., 204, 356, 10.1006/excr.1993.1043 · DOI · Paper page
- Potter, 2005, Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state, J. Biol. Chem., 280, 31906, 10.1074/jbc.M505568200 · DOI · Paper page
- Prewitt, 2015, Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension, J. Biol. Chem., 290, 960, 10.1074/jbc.M114.591057 · DOI
- Rosendahl, 2002, Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation, Am. J. Respir. Cell Mol. Biol., 27, 160, 10.1165/ajrcmb.27.2.4779 · DOI
- Rudini, 2008, VE-cadherin is a critical endothelial regulator of TGF-beta signalling, EMBO J., 27, 993, 10.1038/emboj.2008.46 · DOI
- Sanvitale, 2013, A new class of small molecule inhibitor of BMP signaling, PLoS ONE, 8, e62721, 10.1371/journal.pone.0062721 · DOI · Paper page
- Scharpfenecker, 2007, BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis, J. Cell Sci., 120, 964, 10.1242/jcs.002949 · DOI · Paper page
- Sidibe, 2014, VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs, Am. J. Physiol. Heart Circ. Physiol., 307, H455, 10.1152/ajpheart.00774.2013 · DOI
- Sieber, 2009, Recent advances in BMP receptor signaling, Cytokine Growth Factor Rev., 20, 343, 10.1016/j.cytogfr.2009.10.007 · DOI · Paper page
- Simic, 2006, Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption, J. Biol. Chem., 281, 25509, 10.1074/jbc.M513276200 · DOI · Paper page
- Sorescu, 2003, Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response, J. Biol. Chem., 278, 31128, 10.1074/jbc.M300703200 · DOI · Paper page
- Sorescu, 2004, Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase, Circ. Res., 95, 773, 10.1161/01.RES.0000145728.22878.45 · DOI · Paper page
- Thawani, 2010, Bone morphogenetic proteins and cancer: review of the literature, Neurosurgery, 66, 233, 10.1227/01.NEU.0000363722.42097.C2 · DOI
- Thymiakou, 2011, Detection of signaling effector-complexes downstream of BMP4 using in situ PLA, a proximity ligation assay, J. Vis. Exp., e2631, 10.3791/2631 · DOI
- Valdimarsdottir, 2002, Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells, Circulation, 106, 2263, 10.1161/01.CIR.0000033830.36431.46 · DOI · Paper page
- Vukicevic, 2014, The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing, Int. Orthop., 38, 635, 10.1007/s00264-013-2201-1 · DOI
- Wallez, 2007, Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site, Oncogene, 26, 1067, 10.1038/sj.onc.1209855 · DOI · Paper page
- Walshe, 2009, TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature, PLoS ONE, 4, e5149, 10.1371/journal.pone.0005149 · DOI · Paper page
- Weis, 2005, Pathophysiological consequences of VEGF-induced vascular permeability, Nature, 437, 497, 10.1038/nature03987 · DOI · Paper page
- Wong, 2005, Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension, Am. J. Respir. Cell Mol. Biol., 33, 438, 10.1165/rcmb.2005-0103OC · DOI · Paper page
- Xiao, 2003, Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells, J. Biol. Chem., 278, 19199, 10.1074/jbc.M211746200 · DOI · Paper page
- Xiao, 2003, Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells, J. Cell Biol., 163, 535, 10.1083/jcb.200306001 · DOI · Paper page
- Xiao, 2005, p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin, Mol. Biol. Cell, 16, 5141, 10.1091/mbc.E05-05-0440 · DOI · Paper page
Cited by
Cadherins in early neural development
Punovuori, K., Malaguti, M., & Lowell, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03815-9 · Cited by 39
Zhong, M., Wu, W., Wang, Y., Mao, H., Song, J., Chen, S., & Zhu, D. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003192 · Cited by 28
ST6GAL1 negatively regulates monocyte transendothelial migration and atherosclerosis development
Zhang, J., Liu, Y., Deng, X., Chen, L., Yang, X., & Yu, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.053 · Cited by 23
Steenhuis, M., Koningstein, G. M., Oswald, J., Pick, T., O’Keefe, S., Koch, H., Cavalié, A., Whitehead, R. C., Swanton, E., High, S., et al. (2021) · Molecular Microbiology · doi:10.1111/mmi.14589 · Cited by 11
Metadata
- Authors
- Benn, A., Bredow, C., Casanova, I., Vukičević, S., & Knaus, P.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2016-01-01
- Volume
- 129
- Issue
- 1
- Pages
- 206-218
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2177201093
- Cited by
- 81
- References
- 6
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. https://app.cochat.ai/papers/10.1242/jcs.179960
- The paper
- Benn, A., Bredow, C., Casanova, I., Vukičević, S., & Knaus, P. (2016). VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. Journal of Cell Science. https://doi.org/10.1242/jcs.179960
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.